These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 19630098)

  • 1. Could quantitative liver function tests gain wide acceptance among hepatologists?
    Tarantino G
    World J Gastroenterol; 2009 Jul; 15(28):3457-61. PubMed ID: 19630098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Foreign substances as indicators of liver function].
    Preisig R
    Schweiz Med Wochenschr Suppl; 1985; 19():36-42. PubMed ID: 3864235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overnight salivary caffeine clearance: a liver function test suitable for routine use.
    Jost G; Wahlländer A; von Mandach U; Preisig R
    Hepatology; 1987; 7(2):338-44. PubMed ID: 3557314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of quantitative liver function tests in HIV-positive patients under anti-retroviral therapy.
    Miller M; Kahraman A; Ross B; Beste M; Gerken G
    Eur J Med Res; 2009 Sep; 14(9):369-77. PubMed ID: 19748856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential use of pharmacological markers to quantitatively assess liver function during liver transplantation surgery.
    Gao L; Ramzan I; Baker AB
    Anaesth Intensive Care; 2000 Aug; 28(4):375-85. PubMed ID: 10969363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic tests to study liver function.
    Burra P; Masier A
    Eur Rev Med Pharmacol Sci; 2004; 8(1):19-21. PubMed ID: 15209151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative liver functions in Turner syndrome with and without hormone replacement therapy.
    Gravholt CH; Poulsen HE; Ott P; Christiansen JS; Vilstrup H
    Eur J Endocrinol; 2007 Jun; 156(6):679-86. PubMed ID: 17535868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Intravenous loading with galactose as a liver function test. Methods and clinical value].
    Kuntz HD; Kuntz E
    Fortschr Med; 1983 Jun; 101(21):999-1004. PubMed ID: 6873856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of liver function: the current situation.
    Van Thiel DH; Hassanein T
    J Okla State Med Assoc; 1995 Jan; 88(1):11-6. PubMed ID: 7897548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of quantitative methods to assess hepatic function: Pugh's classification, indocyanine green, antipyrine, and dextromethorphan.
    Figg WD; Dukes GE; Lesesne HR; Carson SW; Songer SS; Pritchard JF; Hermann DJ; Powell JR; Hak LJ
    Pharmacotherapy; 1995; 15(6):693-700. PubMed ID: 8602375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of quantitative liver function tests to clinical, laboratory chemical and biopsy findings in patients with liver diseases].
    Albers I; Hartmann H; Creutzfeldt W
    Z Gastroenterol; 1988 Feb; 26(2):130-6. PubMed ID: 2577930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic clearances of antipyrine, indocyanine green, and galactose in normal subjects and in patients with chronic liver diseases.
    Kawasaki S; Sugiyama Y; Iga T; Hanano M; Beppu T; Sugiura M; Sanjo K; Idezuki Y
    Clin Pharmacol Ther; 1988 Aug; 44(2):217-24. PubMed ID: 3396264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of new approaches to assessing hepatic function in animals.
    Cornelius CE
    Vet Res Commun; 1987; 11(5):423-41. PubMed ID: 3328402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimation of functional liver reserve in patients before cardiac surgery using antipyrine plasma clearance test.
    Takeda M; Furuse A; Kawauchi M; Kotsuka Y; Takamoto S
    J Cardiovasc Surg (Torino); 1999 Dec; 40(6):817-23. PubMed ID: 10776711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive assessment of liver function.
    Helmke S; Colmenero J; Everson GT
    Curr Opin Gastroenterol; 2015 May; 31(3):199-208. PubMed ID: 25714706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caffeine intake, fasting plasma caffeine and caffeine clearance in patients with liver diseases.
    Marchesini G; Checchia GA; Grossi G; Lolli R; Bianchi GP; Zoli M; Pisi E
    Liver; 1988 Aug; 8(4):241-6. PubMed ID: 3419291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver function assessment by drug metabolism.
    Barstow L; Small RE
    Pharmacotherapy; 1990; 10(4):280-8. PubMed ID: 2388874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How to assess liver function?
    Kortgen A; Recknagel P; Bauer M
    Curr Opin Crit Care; 2010 Apr; 16(2):136-41. PubMed ID: 22534730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fasting plasma caffeine concentration. A guide to the severity of chronic liver disease.
    Wahlländer A; Renner E; Preisig R
    Scand J Gastroenterol; 1985 Nov; 20(9):1133-41. PubMed ID: 4089523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Quantification of the drug-metabolizing enzyme system in liver diseases: a comparison between antipyrine saliva clearance and the aminopyrine breath test].
    von Mandach U; Jost G; Preisig R
    Schweiz Med Wochenschr; 1985 May; 115(19):651-8. PubMed ID: 3923620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.